Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples

Autor: Ditte Møller Ejegod, Jette Junge, Maria Franzmann, Benny Kirschner, Fabio Bottari, Mario Sideri, Maria-Teresa Sandri, Jesper Bonde
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Papillomavirus Research, Vol 2, Iss , Pp 31-37 (2016)
Druh dokumentu: article
ISSN: 2405-8521
DOI: 10.1016/j.pvr.2016.01.003
Popis: Background: The novel BD OnclarityTM HPV assay (Onclarity) on the BD Viper™ LT system (BD Diagnostics, Sparks, MD), detects E6/E7 DNA from 13 high-risk HPV genotypes and HPV66. We compared the analytical and clinical performance of the Onclarity Assay to that of Hybrid Capture 2 and LINEAR ARRAY using adjudicated histological outcomes from Danish women referred for colposcopy. Methods: 276 women from Copenhagen, Denmark were referred for colposcopy with abnormal cytology and/or a positive HPV test. Two samples for HPV analysis were taken in BD SurePath™ and in the BD cervical brush diluent (CBD) media. ClinicalTrial gov. identifier: NCT01671462, Ethical Approval: H-4-2012-070. Results: Histology was normal in 84 (31%) women, 70 (26%) had CIN1, 47 (17%) CIN2, and 68 (25%) had CIN3. The Onclarity assay detected 67 out of 68 (99%) ≥CIN3 and 113/115 (98%) ≥CIN2. The specificities for
Databáze: Directory of Open Access Journals